Kotkoskie L A, Butt M T, Selinger E, Freeman C, Weiner M L
FMC Corporation, Princeton, NJ 08543, USA.
J Anat. 1996 Dec;189 ( Pt 3)(Pt 3):531-5.
A subchronic toxicity study was conducted to evaluate the potential toxicological effects associated with intestinal translocation of a special fine particle size (median particle size 6 microns) microcrystalline cellulose (MCC). Four groups of Sprague-Dawley rats (20/sex/group) received either 0 (control), 500, 2500 or 5000 mg/kg/day MCC (25% w/v in tap water) daily by oral gavage for 90 d. At study termination, organs and tissues from high-dose and control animals, including multiple sections of intestine with gut-associated lymphoid tissue, were processed for light microscopy with subsequent examination under polarised light for the presence of birefringent MCC particles. None were observed in any tissue examined. No toxicologically significant effects or lesions were found in any other parameter or organ evaluated. The 'no observed adverse effect level' (NOAEL) for toxicological effects was greater than 5000 mg/kg/day MCC, which was the highest dosage tested. These results further verify the safety of commercial MCC products for use in food and pharmaceutical applications.
进行了一项亚慢性毒性研究,以评估与一种特殊细粒度(中位粒径6微米)微晶纤维素(MCC)的肠道转运相关的潜在毒理学效应。四组斯普拉格-道利大鼠(每组雌雄各20只)每天经口灌胃给予0(对照)、500、2500或5000 mg/kg/天的MCC(在自来水中为25% w/v),持续90天。在研究结束时,对高剂量组和对照组动物的器官和组织进行处理,包括带有肠道相关淋巴组织的多段肠道,用于光学显微镜检查,随后在偏振光下检查是否存在双折射MCC颗粒。在所检查的任何组织中均未观察到。在评估的任何其他参数或器官中均未发现毒理学上显著的效应或病变。毒理学效应的“未观察到有害作用水平”(NOAEL)大于5000 mg/kg/天的MCC,这是测试的最高剂量。这些结果进一步证实了商业MCC产品用于食品和制药应用的安全性。